Sinusoidal endothelial dysfunction precedes inflammation and fibrosis in a model of NAFLD
- PMID: 22509248
- PMCID: PMC3317918
- DOI: 10.1371/journal.pone.0032785
Sinusoidal endothelial dysfunction precedes inflammation and fibrosis in a model of NAFLD
Abstract
Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome. Most morbidity associated with the metabolic syndrome is related to vascular complications, in which endothelial dysfunction is a major pathogenic factor. However, whether NAFLD is associated with endothelial dysfunction within the hepatic vasculature is unknown. The aims of this study were to explore, in a model of diet-induced overweight that expresses most features of the metabolic syndrome, whether early NAFLD is associated with liver endothelial dysfunction. Wistar Kyoto rats were fed a cafeteria diet (CafD; 65% of fat, mostly saturated) or a control diet (CD) for 1 month. CafD rats developed features of the metabolic syndrome (overweight, arterial hypertension, hypertryglyceridemia, hyperglucemia and insulin resistance) and liver steatosis without inflammation or fibrosis. CafD rats had a significantly higher in vivo hepatic vascular resistance than CD. In liver perfusion livers from CafD rats had an increased portal perfusion pressure and decreased endothelium-dependent vasodilation. This was associated with a decreased Akt-dependent eNOS phosphorylation and NOS activity. In summary, we demonstrate in a rat model of the metabolic syndrome that shows features of NAFLD, that liver endothelial dysfunction occurs before the development of fibrosis or inflammation.
Conflict of interest statement
Figures
Similar articles
-
Insulin resistance and liver microcirculation in a rat model of early NAFLD.J Hepatol. 2011 Nov;55(5):1095-102. doi: 10.1016/j.jhep.2011.01.053. Epub 2011 Feb 26. J Hepatol. 2011. PMID: 21356259
-
Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice.J Lipid Res. 2011 Sep;52(9):1626-35. doi: 10.1194/jlr.M016246. Epub 2011 Jun 20. J Lipid Res. 2011. PMID: 21690266 Free PMC article.
-
Increased intrahepatic resistance in severe steatosis: endothelial dysfunction, vasoconstrictor overproduction and altered microvascular architecture.Lab Invest. 2012 Oct;92(10):1428-39. doi: 10.1038/labinvest.2012.103. Epub 2012 Aug 13. Lab Invest. 2012. PMID: 22890552
-
Metabolic syndrome in childhood from impaired carbohydrate metabolism to nonalcoholic fatty liver disease.J Am Coll Nutr. 2011 Oct;30(5):295-303. doi: 10.1080/07315724.2011.10719972. J Am Coll Nutr. 2011. PMID: 22081615 Review.
-
The role of non-alcoholic fatty liver disease in cardiovascular disease.Dig Dis. 2010;28(1):210-3. doi: 10.1159/000282088. Epub 2010 May 7. Dig Dis. 2010. PMID: 20460913 Review.
Cited by
-
Angiodiversity and organotypic functions of sinusoidal endothelial cells.Angiogenesis. 2021 May;24(2):289-310. doi: 10.1007/s10456-021-09780-y. Epub 2021 Mar 21. Angiogenesis. 2021. PMID: 33745018 Free PMC article. Review.
-
Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease.World J Gastroenterol. 2018 Mar 21;24(11):1239-1249. doi: 10.3748/wjg.v24.i11.1239. World J Gastroenterol. 2018. PMID: 29568204 Free PMC article.
-
Expansion of macrophage and liver sinusoidal endothelial cell subpopulations during non-alcoholic steatohepatitis progression.iScience. 2023 Apr 5;26(5):106572. doi: 10.1016/j.isci.2023.106572. eCollection 2023 May 19. iScience. 2023. PMID: 37124414 Free PMC article.
-
Upregulation of miR21 and repression of Grhl3 by leptin mediates sinusoidal endothelial injury in experimental nonalcoholic steatohepatitis.PLoS One. 2015 Feb 6;10(2):e0116780. doi: 10.1371/journal.pone.0116780. eCollection 2015. PLoS One. 2015. PMID: 25658689 Free PMC article.
-
The Emerging Role of Hepatocellular eNOS in Non-alcoholic Fatty Liver Disease Development.Front Physiol. 2020 Jul 3;11:767. doi: 10.3389/fphys.2020.00767. eCollection 2020. Front Physiol. 2020. PMID: 32719616 Free PMC article. Review.
References
-
- Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation %20; 2009;120:1640–1645. - PubMed
-
- Reaven G. Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease. Circulation. 2002;106:286–288. - PubMed
-
- Gallagher EJ, Leroith D, Karnieli E. Insulin resistance in obesity as the underlying cause for the metabolic syndrome. Mt Sinai J Med. 2010;77:511–523. - PubMed
-
- Perlemuter G, Bigorgne A, Cassard-Doulcier AM, Naveau S. Nonalcoholic fatty liver disease: from pathogenesis to patient care. Nat Clin Pract Endocrinol Metab. 2007;3:458–469. - PubMed
-
- Lewis JR, Mohanty SR. Nonalcoholic fatty liver disease: a review and update. Dig Dis Sci. 2010;55:560–578. - PubMed